SCG142 TCR-T Cells

HPV-targeted T cell receptor-engineered T cells · The Affiliated Hospital of Qingdao University

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SCG142 TCR-T Cells, covering 2024-07-17 to 2024-08-09. Get the full timeline:

Most recent: Clinical Trial Update: SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas [Phase 1]